Mishra, Anjali <br/><br/>
Hypoxia stabilizes GAS6/Axl signaling in metastatic prostate cancer.  [electronic resource] 

 -  Molecular cancer research : MCR  Jun 2012 
 - 703-12 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1557-3125 
<br/><br/><label>Standard No.: </label>10.1158/1541-7786.MCR-11-0569  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antimutagenic Agents--pharmacology<br/>Blotting, Western<br/>Cadherins--metabolism<br/>Cell Hypoxia<br/>Cell Line, Tumor<br/>Cobalt--pharmacology<br/>Down-Regulation--drug effects<br/>Epithelial-Mesenchymal Transition<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Hypoxia-Inducible Factor 1, alpha Subunit--metabolism<br/>Intercellular Signaling Peptides and Proteins--genetics<br/>Male<br/>Neoplasm Metastasis<br/>Prostatic Neoplasms--genetics<br/>Proto-Oncogene Proteins--genetics<br/>RNA Interference<br/>Receptor Protein-Tyrosine Kinases--genetics<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Signal Transduction<br/>Tissue Array Analysis<br/>Axl Receptor Tyrosine Kinase